{"id":"adrenergic-blocker-propranolol","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"1-5%","effect":"Bronchospasm"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This results in decreased heart rate, blood pressure, and cardiac output. Propranolol also has a blocking effect on beta-2 receptors in the bronchial tubes, which can help to alleviate asthma symptoms.","oneSentence":"Propranolol blocks the action of beta-adrenergic receptors in the body, reducing the effects of the sympathetic nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:00:06.246Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"},{"name":"Atrial fibrillation for stroke prevention"},{"name":"Essential tremor"},{"name":"Migraine prophylaxis"}]},"trialDetails":[{"nctId":"NCT07353294","phase":"PHASE1","title":"Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Bladder Urothelial Carcinoma, Lymph Node Metastasis","enrollment":12},{"nctId":"NCT05387512","phase":"","title":"A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-12","conditions":"Lung Cancer","enrollment":59},{"nctId":"NCT02789982","phase":"PHASE3","title":"Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05-27","conditions":"Post-traumatic Stress Disorder","enrollment":364},{"nctId":"NCT05106179","phase":"PHASE4","title":"The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma","status":"UNKNOWN","sponsor":"Center for Vascular Pathology, Moscow","startDate":"2021-12","conditions":"Spinal Tumor, Spinal Hemangioma, Beta Blocker Toxicity","enrollment":1000},{"nctId":"NCT04320589","phase":"PHASE2","title":"the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2019-06-30","conditions":"Pheochromocytoma","enrollment":30},{"nctId":"NCT03919461","phase":"PHASE2","title":"Colorectal Metastasis Prevention International Trial 2","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2019-02-28","conditions":"Colorectal Neoplasms","enrollment":200},{"nctId":"NCT00241904","phase":"PHASE4","title":"Reducing Total Cardiovascular Risk in an Urban Community","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2006-05","conditions":"Cardiovascular Diseases, Heart Diseases, Coronary Disease","enrollment":525},{"nctId":"NCT01316952","phase":"","title":"Coreg and HSRs-Updated Analysis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06","conditions":"Hypersensitivity","enrollment":1},{"nctId":"NCT00888797","phase":"PHASE3","title":"β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2010-01","conditions":"Colorectal Neoplasms","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":143,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"β-adrenergic blocker propranolol","genericName":"β-adrenergic blocker propranolol","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Propranolol blocks the action of beta-adrenergic receptors in the body, reducing the effects of the sympathetic nervous system. Used for Hypertension, Angina pectoris, Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}